Why is Boji Medical Technology Co., Ltd. ?
1
With a growth in Net Profit of 322.01%, the company declared Outstanding results in Sep 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at CNY 52.72 MM
- NET PROFIT(HY) Higher at CNY 17.19 MM
- INVENTORY TURNOVER RATIO(HY) Highest at 2.43 times
2
With ROE of 0.76%, it has a very expensive valuation with a 3.83 Price to Book Value
- Over the past year, while the stock has generated a return of 30.90%, its profits have fallen by -83.4%
- At the current price, the company has a high dividend yield of 0.1
How much should you buy?
- Overall Portfolio exposure to Boji Medical Technology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Boji Medical Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Boji Medical Technology Co., Ltd.
27.45%
1.09
46.80%
China Shanghai Composite
23.81%
1.82
13.09%
Quality key factors
Factor
Value
Sales Growth (5y)
24.56%
EBIT Growth (5y)
-167.65%
EBIT to Interest (avg)
9.76
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.70
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
16.33%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.35%
ROE (avg)
4.53%
Valuation Key Factors 
Factor
Value
P/E Ratio
503
Industry P/E
Price to Book Value
3.83
EV to EBIT
-1041.91
EV to EBITDA
148.40
EV to Capital Employed
4.83
EV to Sales
4.73
PEG Ratio
NA
Dividend Yield
0.11%
ROCE (Latest)
-0.46%
ROE (Latest)
0.76%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 52.72 MM
NET PROFIT(HY)
Higher at CNY 17.19 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.43 times
NET SALES(Q)
Highest at CNY 222.87 MM
-17What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY 4.1 MM has Fallen at -63.7%
NET PROFIT(Q)
At CNY 5.95 MM has Fallen at -53.24%
ROCE(HY)
Lowest at 0.74%
RAW MATERIAL COST(Y)
Grown by 11.96% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.49 times
Here's what is working for Boji Medical Technology Co., Ltd.
Operating Cash Flow
Highest at CNY 52.72 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Inventory Turnover Ratio
Highest at 2.43 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Highest at CNY 222.87 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Here's what is not working for Boji Medical Technology Co., Ltd.
Pre-Tax Profit
At CNY 4.1 MM has Fallen at -63.7%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 5.95 MM has Fallen at -53.24%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 2.49 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 11.96% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at CNY 0.83 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income






